Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Arbe Robotics Ltd (ARBE)
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
$0.42-1.20%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for ARBE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improvement in investor sentiment and stock price stability | A supporting condition in Arbe Robotics Ltd's published investment case. The stated target is stock price stabilizes above $0.60. | Under Pressure | stock price falls below $0.40 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 19, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is speculative growth, with the case depending on future opportunity rather than current earnings strength. The thesis is in watch mode: recent performance is weak versus its industry cohort, but the evidence does not show a fresh break.
ARBE is valued at a premium to peers, with low confidence in the valuation model and optionality driving the gap. The evidence says the valuation is expensive, but does not show that the market has priced in the full combination of weak fundamentals and turbulence.
Near term, the evidence points to continued pressure from weak financial performance and a loss-making profile. The sector backdrop is neutral, but a slowdown in growth could weigh more heavily on growth-sensitive technology companies.
A more favorable setup would depend on rate cuts or stabilization among technology sector bellwethers. A material slowdown in GDP growth from its current level would be an unfavorable swing factor.
Over the next 1 to 3 years, the thesis hinges on whether the business can improve from a weak, loss-making starting point while sector conditions support growth. Confidence is low, and the evidence supports caution about the thesis rather than a settled view. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Arbe Robotics is positioned to capitalize on the growing demand for advanced imaging radar in autonomous vehicles. |
| Intact |
| failure to launch any new products |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth to $15.57 million in FY27 | A primary condition in Arbe Robotics Ltd's published investment case. The stated target is >=15.57 million. | Intact | revenue falls below $4.08 million in FY26 | Revenue: $703,000 FY2026-Q2; GAAP. Published target: >=15.57 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 2026703,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.22 → $-0.22 · observed estimates
$0.02B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-27 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-09-28 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-09-29 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-09-30 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-01 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-02 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-03 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-04 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-05 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-06 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-07 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-08 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-09 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-10 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-11 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-12 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-13 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-14 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-15 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-16 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-17 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-18 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-19 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-20 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-21 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-22 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-23 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-24 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-25 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-26 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-27 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-28 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-29 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-30 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-10-31 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-11-01 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-11-02 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-11-03 | $-0.22 | $15,566,333 | 1 / 2 |
| 2026-11-04 | $-0.22 | $15,566,333 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.